Namely, postmortem analysis of brains from patients diagnosed with Parkinson's disease (PD), which is characterized by dopaminergic neurodegeneration, reveal reduced PCNA staining (proxy of reduced proliferation) in the SVZ compared to subjects that did not have a history of a neuropsychiatric disorder (Höglinger et al., 2004). This evidence concerns the gene PCNA and Parkinson disease.